Welcome to our dedicated page for Symbotic news (Ticker: $SYM), a resource for investors and traders seeking the latest updates and insights on Symbotic stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Symbotic's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Symbotic's position in the market.
Symbotic Inc. (Nasdaq: SYM) reported revenue of $424 million, a net loss of $41 million, and adjusted EBITDA of $22 million for the second quarter of fiscal 2024. The company showed significant improvement from the previous year in terms of revenue, net loss, and adjusted EBITDA. Cash, cash equivalents, and marketable securities also saw an increase, reaching $951 million at the end of the quarter. Symbotic's leadership highlighted advancements in software and hardware that will benefit customers, accelerate deployment times, and increase deployment capacity. The company projects revenue of $450 million to $470 million and adjusted EBITDA of $27 million to $29 million for the third quarter of fiscal 2024.
